Targeting HER2+ breast cancer cells: Lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles-Reference-Cited by-同舟云学术

Targeting HER2+ breast cancer cells: Lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles

Published:2013-12 Issue:2 Volume:172 Page:395-404
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Owen Shawn C.,Patel Nish,Logie Jennifer,Pan Guohua,Persson Helena,Moffat Jason,Sidhu Sachdev S.,Shoichet Molly S.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference53 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat. Rev. Cancer,2005

2. The EGF receptor family as targets for cancer therapy;Mendelsohn;Oncogene,2000

3. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer;Roepstorff;Histochem. Cell Biol.,2008

4. Trastuzumab — mechanism of action and use in clinical practice;Hudis;N. Engl. J. Med.,2007

5. Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4;Albanell,2003

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetically Actuated Nanomaterials in Biomedical Applications;Advanced NanoBiomed Research;2024-07-17

2. Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy;Current Medicinal Chemistry;2024-02

3. Reversible Protection and Targeted Delivery of DNA Origami with a Disulfide‐Containing Cationic Polymer;Small;2023-11-02

4. Mapping Antibody Domain Exposure on Nanoparticle Surfaces Using DNA-PAINT;ACS Nano;2023-06-07

5. Nanoparticle Targeting with Antibodies in the Central Nervous System;BME Frontiers;2023-01